ArticleCurrent issues in molecular biology2024

Open-Label Clinical Trial on the Impact of Autologous Dendritic Cell Therapy on Albuminuria and Inflammatory Biomarkers (Interleukin-6, Interleukin-10, Tumor Necrosis Factor α) in Diabetic Kidney Disease (DKD).

Jonny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.